February 27, 2018 / 10:09 PM / 7 months ago

BRIEF-Theravance Biopharma Q4 Revenue $4.5 Million

Feb 27 (Reuters) - Theravance Biopharma Inc:

* THERAVANCE BIOPHARMA, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 REVENUE $4.5 MILLION

* ‍ANTICIPATES FULL YEAR 2018 OPERATING LOSS, EXCLUDING SHARE-BASED COMPENSATION, WILL BE IN RANGE OF $180.0 TO $200.0 MILLION​

* QTRLY ‍LOSS PER SHARE $1.64​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below